Medigene AG
MDGEF · OTC
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 50.7% | -3.1% | -48.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 82.7% | 75.7% | 69.9% | 80.4% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -132.6% | -297.8% | -218.7% | 291.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -150.3% | -310% | -227.5% | -373.1% |
| EPS Diluted | -0.52 | -0.37 | -0.28 | -0.91 |
| % Growth | -40.5% | -32.1% | 69.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |